Title: An S, et al. Small-molecule PROTACs: An emerging and promising approach for the development of targeted therapy drugs. EBioMedicine. 2018 Oct;36:553-562
133345-66-1
937601-92-8 | Ethyl 4-[2-(4-hydroxypiperidin-1-yl)ethoxy]benzoate | AA00IHQ1 | MFCD08689771
942603-69-2 | 2-Benzyl 1-tert-butyl 5-oxopyrrolidine-1,2-dicarboxylate | AA00IHXP | MFCD08277159
944804-79-9 | 2-Amino-5-bromothiazole-4-carbonitrile | AA00II4M | MFCD11109851
946493-27-2 | 3,5-Dimethylpyrazine-2-carboxylic acid | AA00IIC8 | MFCD18070837
948291-48-3 | 2,6,8-Trimethylquinoline-3-carboxylic acid ethyl ester | AA00IIHL | MFCD09787540
95104-44-2 | 5-(Hydroxymethyl)-3-phenyl-4-isoxazolecarboxylic acid ethyl ester | AA00IIO1 | MFCD22123831
952511-48-7 | 5-Bromo-4-methyl-1h-benzo[d]imidazole | AA00IITA | MFCD18642426
955028-68-9 | 6-Azaspiro[2.5]octan-4-ol hcl | AA00IJ2R | MFCD21607169
956397-18-5 | 3-tert-Butyl-1-(2-chlorophenyl)-1h-pyrazol-5-amine | AA00IJ7F | MFCD04115098
957780-59-5 | Fmoc-asn(trt)-thr(psime,mepro)-oh | AA00IJDF | MFCD08064322